Adderall

How Hard Is It to Find Adderall in Stock?

Adderall is one of the hardest medications to find in the United States in 2026. The FDA officially declared an Adderall shortage in October 2022, and as of early 2026, both immediate-release and extended-release formulations remain in active shortage according to the FDA and ASHP. The shortage has now persisted for over three years, making it one of the longest-running drug shortages in recent American history.

The 20mg and 30mg IR tablets and the 10mg and 20mg XR capsules have been the most consistently unavailable. Availability varies significantly by region and by individual pharmacy — independent pharmacies often have supply when chain pharmacies don't, as they use different drug wholesalers. DEA quota increases in late 2025 and January 2026 are gradually improving supply, but full relief is not expected until late 2026 at the earliest.

Use Medfinder to check real-time Adderall availability at pharmacies near you. Rather than calling dozens of pharmacies, Medfinder's inventory search lets you quickly identify which pharmacies near you are likely to have your specific strength in stock.

Who Can Prescribe Adderall?

Because Adderall is a Schedule II controlled substance, it can only be prescribed by a licensed healthcare provider who holds an active DEA registration authorizing them to prescribe Schedule II medications. The provider must conduct a clinical evaluation establishing a valid medical indication before issuing a prescription.

The following types of providers commonly prescribe Adderall:

Psychiatrists — the most common prescribers of Adderall for ADHD; specialize in diagnosing and treating psychiatric conditions including ADHD and comorbidities

Primary care physicians (PCPs) — family medicine and internal medicine doctors frequently manage ongoing Adderall prescriptions and can initiate treatment

Pediatricians — typically the initial prescribers for children and adolescents with ADHD; complex cases may be referred to child psychiatrists

Neurologists — may prescribe Adderall for both ADHD and narcolepsy; sleep medicine specialists also prescribe for narcolepsy

Nurse Practitioners (NPs) and Physician Assistants (PAs) — can prescribe Schedule II medications including Adderall in most states when DEA-registered; prescribing authority for controlled substances varies by state

Telehealth prescribing of Adderall is available through several platforms in many states, including Talkiatry, Done (doneadhd.com), and Ahead. DEA rules for telehealth prescribing of Schedule II medications have been extended multiple times since the pandemic and continue to evolve in 2026 — verify current requirements for your state.

Is Adderall a Controlled Substance?

Yes. Adderall (amphetamine mixed salts) is a Schedule II controlled substance (CII) under the Controlled Substances Act, enforced by the DEA. Schedule II is the most restrictive classification for medications with accepted medical uses — it means the drug has a high potential for abuse that may lead to severe psychological or physical dependence.

Practical implications for patients: Adderall requires a written or electronic prescription from a DEA-registered provider. Schedule II prescriptions cannot be refilled — a new prescription is required each month. In most states, pharmacies cannot transfer Schedule II prescriptions between locations. Some states permit providers to write multiple post-dated prescriptions at one visit to cover several months. Telehealth prescribing rules for Schedule II medications have been evolving since the pandemic — check current DEA regulations.

The DEA's control over Adderall extends to production as well — annual Aggregate Production Quotas (APQs) limit how much amphetamine can be manufactured in the U.S. each year. These quota limits have been a primary driver of the ongoing Adderall shortage.

Common Side Effects of Adderall

The most common side effects experienced at therapeutic doses include:

Decreased appetite and weight loss

Insomnia or difficulty sleeping

Dry mouth

Headache

Increased heart rate and blood pressure

Anxiety or irritability

Stomach upset or nausea

Serious Side Effects

Seek immediate medical attention for any of the following:

Chest pain, shortness of breath, or fainting (possible cardiovascular event)

Signs of psychosis: hallucinations, paranoia, or delusional thinking

Manic symptoms or severe mood changes

Signs of serotonin syndrome: rapid heartbeat, high temperature, muscle twitching, agitation

Severe allergic reaction: rash, hives, swelling of face, lips, or throat

Growth suppression in children (monitor height/weight at regular checkups)

Final Thoughts on Adderall

Adderall has helped millions of people with ADHD and narcolepsy live more manageable, productive lives. With over 32 million prescriptions in 2023, it remains one of America's most essential psychiatric medications. When taken as prescribed, at therapeutic doses, Adderall is safe and effective for the vast majority of patients.

The biggest challenge in 2026 is access, not efficacy. The ongoing shortage — now in its fourth year — means many patients struggle to consistently fill their prescriptions. DEA quota increases in 2025 and 2026 offer reasons for cautious optimism, but supply remains inconsistent. Strategies like checking multiple pharmacies, working with your prescriber on dose flexibility, and considering alternatives like generic lisdexamfetamine can help bridge the gap while the system catches up.

If you're struggling to find Adderall in stock, Medfinder can help you locate real-time inventory at pharmacies near you — saving you the frustration of calling pharmacy after pharmacy without results.